20978 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons Interferons [IFN]
Sub-classes:PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, PREVENTING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#2ORALLY BIOAVAILABLE LIPID-BASED CONSTRUCTS
#3THERAPEUTIC DRUG COMBINATIONS FOR TREATING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#4INDOLIUM-BASED STABILIZERS OF HYDROPHOBIC DRUGS
#5TREATMENT OF HEPATITIS DELTA VIRUS INFECTION
#6REPLICANT / STAV FOR DISEASE TREATMENT AND METHODS OF USE
#7USE OF IFN-LAMBDA MRNA FOR TREATING VIRAL INFECTIONS
#8ORALLY BIOAVAILABLE LIPID-BASED CONSTRUCTS
#9EXTRACELLULAR VESICLE COMPOSITES AND THEIR USES IN THE TREATMENT OF LIVER INJURY
#10MOLECULAR INDEXING OF PROTEINS BY SELF ASSEMBLY (MIPSA) FOR EFFICIENT PROTEOMIC INVESTIGATIONS
#11METHOD FOR REDUCING FLU-LIKE SYMPTOMS ASSOCIATED WITH INTRAMUSCULAR ADMINISTRATION OF INTERFERON USING A FAST TITRATION ESCALATING DOSING REGIMEN
#12TOXIN-DERIVED DELIVERY CONSTRUCTS
#13COMPOSITIONS INCLUDING IFNE AND USES THEREOF
#14DOSAGE REGIMEN FOR PEGYLATED INTERFERON
#15TOPICAL THERAPEUTIC FORMULATIONS
#16METHODS RELATED TO ADMINISTERING IMMUNOSUPPRESSANTS AND THERAPEUTIC MACROMOLECULES AT A REDUCED PHARMACODYNAMICALLY EFFECTIVE DOSE
#17METHODS FOR TREATING HEPATITIS B VIRUS INFECTION
#18Drug and Method for Nucleoside (Acid) Drug Therapy of Limiting Chronic Hepatitis B
#19INTERACTION OF FIBROBLASTS AND IMMUNE CELLS FOR ACTIVATION AND USES THEREOF
#20DEVICE, SYSTEM AND METHODS FOR THE ORAL DELIVERY OF THERAPEUTIC COMPOUNDS
#21COMPOSITIONS AND METHODS FOR ENHANCING CARDIOMYOCYTE TRANSPLANT ENGRAFTMENT
#22METHODS AND COMPOSITIONS FOR IMPROVED MOLECULAR THERAPIES OF MULTIGENIC DISEASES
#23METHODS FOR REDUCING OR SHUTTING DOWN LACTATION IN NON-HUMAN MAMMALS AND REAGENTS THEREFOR
#24PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#25FUSION PROTEIN OF INTERFERON (IFN) AND ANTI-PD-L1 ANTIBODY AND USE THEREOF
#26WILLOW EXTRACT AND ITS USE IN TREATING A VIRAL INFECTION, ALLERGIC REACTION, AND OTHER MEDICAL CONDITIONS
#27THERAPEUTIC AGENT FOR REFRACTORY VIRAL INFECTIONS
#28Method and System of Augmenting Cancer Therapy
#29Treatment of Breast and Other Cancers Using Zinc Chloride Instead of Radiation
#30MULTIVALENT INTERFERON PARTICLES COMPOSITIONS AND METHODS OF USE
#31METHODS AND FORMULATIONS RELATED TO THE INTRATHECAL DELIVERY OF ONCOLYTIC VIRUSES
#32METHODS OF ADMINISTERING IMMUNOSUPPRESSANTS HAVING A SPECIFIED PHARMACODYNAMIC EFFECTIVE LIFE AND THERAPEUTIC MACROMOLECULES FOR THE INDUCTION OF IMMUNE TOLERANCE
#33TOXIN-DERIVED DELIVERY CONSTRUCTS
#34METHODS FOR PREVENTING AND TREATING CHRONIC PAIN
#35SMALL MOLECULE COMPOUNDS
#36INTERFERONS AND NUCLEAR EXPORT INHIBITORS FOR USE IN METHODS OF TREATING CANCER
#37Treatment of hepatitis delta virus infection
#38METHODS OF TREATING CANCERS HAVING A DEREGULATED NRF2/KEAP1 PATHWAY
#39AUTOTRANSPORTER SYSTEM
#40MODULATION OF IFI16 AND STING ACTIVITY
#41USE OF IFN-LAMBDA MRNA FOR TREATING VIRAL INFECTIONS
#42Induction of IL-12 using immunotherapy
#43Compositions and Methods for Enhancing Anti-Viral Therapies
#44STING LEVELS AS A BIOMARKER FOR CANCER IMMUNOTHERAPY
#45LYOPHILIZED POLYMER SCAFFOLD COMPOSITIONS, PROCESSES FOR PREPARATION AND USE IN ANABOLIC WOUND REPAIR
#46Cancer Stem Cell Targeted Cancer Vaccines
#47TREATMENT OF HEPATITIS E VIRUS INFECTION WITH INTERFERON LAMBDA
#48Device, system and methods for the oral delivery of therapeutic compounds
#49ELECTROTRANSFER METHODS FOR TREATING TUMORS
#50BENEFITS OF SUPPLEMENTATION WITH N-ACETYLCYSTEINE AND GLYCINE TO IMPROVE GLUTATHIONE LEVELS
#51Medical use of interferon-lambda for the treatment of fibrosis
#52MICRONEEDLE SYSTEM FOR THE DELIVERY OF INTERFERON
#53TREATMENT OF CANCER WITH IMMUNE STIMULATORS
#54TREATMENT OF CORONAVIRUS INFECTION WITH INTERFERON LAMBDA
#55INTERFERON-BASED DISEASE TREATMENT METHOD
#56OCULAR IMPLANT CONTAINING AN ACTIVE INGREDIENT
#57Compositions and Methods for Treating COVID-19 and/or Acute Respiratory Failure and/or Acute Respiratory Distress Syndrome Using Tetrahydrocannabinol and Compositions Including Same
#58Method for Prohibiting and/or Treating an Eye Condition
#59COMPOSITIONS AND METHODS RELATING TO THE TREATMENT OF DISEASES
#60Increasing Cancer Patient Survival Time by Administration of Dithio-Containing Compounds
#61TREATMENT OF CORONAVIRUS INFECTION WITH INTERFERON LAMBDA
#62METHODS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS
#63COMPOSITIONS AND METHODS FOR TREATING NEOPLASIA
#64Application of TFF2 Protein and IFN-k Protein Combination in Treatment of a Novel Coronavirus Infection
#65TOXIN-DERIVED DELIVERY CONSTRUCTS
#66INTERFERON TAU AS ANTIVIRAL THERAPY
#67Benefits of supplementation with n-acetylcysteine and glycine to improve glutathione levels
#68CAR Peptide for Improved Coronavirus Survival
#69Test to Predict and Evaluate Innate Immune Responses to Infections and Methods of Treatment Thereof
#70PEGYLATED INTERFERON TAU AND COMPOSITIONS AND METHODS THEREOF
#71DOSAGE REGIMEN FOR PEGYLATED INTERFERON
#72NOVEL SUBTITUTED SULFONYLUREA AND SULFOXIMINEUREA DERIVATIVES
#73REAGENTS FOR TREATMENT OF HEPATITIS B VIRUS (HBV) INFECTION AND USE THEREOF
#74Topical therapeutic formulations
#75PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#76Use of sodium dichloroisocyanurate (NaDCC) and a pharmaceutical formulation prepared therefrom
#77STABILIZATION OF AQUEOUS COMPOSITIONS OF PROTEINS WITH DISPLACEMENT BUFFERS
#78Treatment of hepatitis delta virus infection
#79METHODS PROVIDING A THERAPEUTIC MACROMOLECULE AND SYNTHETIC NANOCARRIERS COMPRISING IMMUNOSUPPRESSANT LOCALLY AND CONCOMITANTLY TO REDUCE BOTH TYPE 1 AND TYPE IV HYPERSENSITIVITY
#80COMPOSITIONS AND METHODS FOR REDUCING CYTOKINE EXPRESSION
#81PROTEIN FORMULATIONS AND METHODS OF MAKING SAME
#82METHODS OF REDUCING IMMUNOGENICITY AGAINST FACTOR VIII IN INDIVIDUALS UNDERGOING FACTOR VIII THERAPY
#83TREATMENT OF GASTROINTESTINAL DISEASE
#84METHODS TO TREAT VIRAL INFECTIONS
#85A METHOD FOR TREATING TUMOR BY USING RECOMBINANT INTERFERON WITH CHANGED SPATIAL CONFIGURATION
#86TREATMENT OF CANCERS WITH GM-CSF ANTAGONISTS
#87Willow extract and its use in treating a viral infection, allergic reaction, and other medical conditions
#88NOVEL SUBSTITUTED SULFOXIMINE DERIVATIVES
#89MEDICAMENT AND FOOD FOR PREVENTING OR TREATING NOVEL CORONAVIRUS PNEUMONIA COVID-19 AND USE THEREOF
#90USE OF IMMUNOCYTOKINE COMPRISING INTERFERON-BETA OR VARIANT THEREOF FOR TREATING HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 POSITIVE CANCER
#91METHOD FOR REDUCING FLU-LIKE SYMPTOMS ASSOCIATED WITH INTRAMUSCULAR ADMINISTRATION OF INTERFERON USING A FAST TITRATION ESCALATING DOSING REGIMEN
#92ANTI-INFECTION EFFECTS OF HNRNPA2B1 AND USE THEREOF
#93GENE THERAPY FOR MESOTHELIOMA
#94METHOD FOR DECREASING ADVERSE-EFFECTS OF INTERFERON
#95MODULATION OF CANCER IMMUNITY WITH TYPE 2 INNATE LYMPHOID CELLS, INTERLEUKIN 33, AND/OR INTERFERON INDUCED PROTEIN 44
#96DENDRITIC CELL IMMUNOTHERAPY
#97MEDICAMENT AND COMBINATION PRODUCT USED FOR PREVENTING, ALLEVIATING AND/OR TREATING FIBROSIS, AND USE THEREOF
#98THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
#99Compounds and pharmaceutical uses thereof
#100METHODS OF TREATING SOLID OR LYMPHATIC TUMORS BY COMBINATION THERAPY
#101FUSED TRICYCLIC PYRAZOLO-DIHYDROPYRAZINYL-PYRIDONE COMPOUNDS AS ANTIVIRALS
#102APPLICATION OF 2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES IN ANTIVIRAL THERAPY
#103METHOD FOR TREATING CANCER WITH KIDNEY PROTECTION
#104Miltefosine for the treatment of viral infections including covid-19
#105METHODS OF ADMINISTERING IMMUNOSUPPRESSANTS HAVING A SPECIFIED PHARMACODYNAMIC EFFECTIVE LIFE AND THERAPEUTIC MACROMOLECULES FOR THE INDUCTION OF IMMUNE TOLERANCE
#106Therapies That Target Autoimmunity For Treating Glaucoma And Optic Neuropathy
#107PEROXIDE REMOVAL FROM DRUG DELIVERY VEHICLE
#108TRANSDERMAL DELIVERY OF HIGH VISCOSITY BIOACTIVE AGENTS
#109Combination Of Local And Systemic Immunomodulative Therapies For Enhanced Treatment of Cancer
#110METHODS FOR DETERMINING DRUG EFFICACY FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA, MULTIPLE MYELOMA, AND MYELOID CANCERS
#111Interaction of fibroblasts and immune cells for activation and uses thereof
#112METHODS OF TREATING TIM-3 ELEVATION
#113COMBINATION THERAPY CONTAINING IMMUNE BOOSTERS, DIGESTIVE ENZYMES AND INTERFERONS FOR CANCER TREATMENT
#114METHODS OF TREATING CANCERS HAVING A DEREGULATED NRF2/KEAP1 PATHWAY
#115Fused tricyclic pyrazolo-dihydropyrazinyl-pyridone compounds as antivirals
#116PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, PREVENTING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#117SMC COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#118COMPOSITIONS AND METHODS USING INTERFERON FOR TREATING VIRAL RESPIRATORY INFECTIONS
#119TREATING SARS-COV-2 INFECTED SUBJECTS WITH SMALL MOLECULE COMPOUNDS
#120Complex coacervate for controlled release and related methods
#121Transluminal Delivery of Viruses for Treatment of Diseased Tissue
#122Methods of use of cyclopamine analogs
#123METHODS OF DETERMINING INTERFERON HAVING DIRECT INHIBITORY EFFECTS ON TUMORS AND USES THEREOF
#124Induction of IL-12 using immunotherapy
#125Methods and compositions for treatment of bone, skin, subcutaneous, mucosal and/or submucosal cancer by percutaneous and/or transmucosal administration of interferon
#126CAPSID ASSEMBLY MODULATOR DOSING REGIMEN
#127Compounds and pharmaceutical uses thereof
#128ANTI-VIRAL COMPOSITIONS AND METHODS OF USE
#129THERAPEUTIC COMBINATIONS OF DRUGS FOR TREATING, PREVENTING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#130Benefits of supplementation with n-acetylcysteine and glycine to improve glutathione levels
#131TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON LAMBDA
#132Microneedle system for applying interferon
#133TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON LAMBDA
#134Fusion protein of interferon (IFN) and anti-PD-L1 antibody and use thereof
#135Protein formulations and methods of making same
#136METHODS OF TREATING MINIMAL RESIDUAL CANCER
#137Toxin-derived delivery constructs for pulmonary delivery
#138Protein formulations and methods of making same
#139Treatment for aggressive cancers by targeting C9ORF72
#140Gene Therapy For Mesothelioma
#141Composition for enhancing breast milk component
#142Methods for diagnosing and treating Alzheimer's disease
#143Cancer stem cell targeted cancer vaccines
#144Modulators of STING (stimulator of interferon genes)
#145COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ATYPICAL BRAF MUTATIONS
#146INHIBITION OF INNATE IMMUNE RESPONSE
#147ANTIVIRAL COMPOUNDS
#148COMPOSITIONS AND METHODS FOR INDUCING TRIPARTITE MOTIF-CONTAINING PROTEIN 16 (TRIM16) SIGNALING
#149VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
#150STING levels as a biomarker for cancer immunotherapy
#151MODIFIED 2' AND 3'-NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS
#152PSMA ANTIBODY-DRUG CONJUGATES
#153Substituted heterocycles as antiviral agents
#154Estrogen receptor ligand treatment for neurodegenerative diseases
#155Orally bioavailable lipid-based constructs
#156Treatment of inflammatory diseases using placental stem cells
#157Hepatitis B antiviral agents
#158HEPATITIS C ANTIVIRAL COMPOSITIONS AND METHODS
#159SMC COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#160Treatment of hepatitis delta virus infection
#161PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
#162PEGYLATED INTERFERON LAMBDA HAVING HIGH ORAL BIOAVAILABILITY AND METHOD FOR PREPARATION THEREOF
#163METHODS FOR THE TREATMENT OF DISEASES AMELIORATED BY PDE4 INHIBITION USING DOSAGE TITRATION OF APREMILAST
#164ANTI-VIRAL COMPOSITIONS CONTAINING PIKFYVE INHIBITORS AND USE THEREOF
#165TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE OR PREVENT ANAPHYLAXIS IN RESPONSE TO A NON-ALLERGENIC ANTIGEN
#166COMPOSITIONS AND METHODS FOR TREATING NIEMANN PICK C DISEASE
#167Device, system and methods for the oral delivery of therapeutic compounds
#168Treatment of cancer with alpha thymosin peptide and PD-1 inhibitors
#169PROTECTIVE METALLOTHIONEIN ANALOG COMPOUNDS, THEIR COMPOSITIONS AND USE THEREOF IN THE TREATMENT OF PATHOGENIC DISEASES
#170Compositions and methods of modulating macrophage activity
#171Methods for reducing or shutting down lactation in non-human mammals and reagents therefor
#172Systems and methods for targeted imaging and ablation of cardiac cells
#173MICRODEVICE AND METHOD FOR TRANSDERMAL DELIVERY AND SAMPLING OF ACTIVE SUBSTANCES
#174Collagen-mimetic peptide mediated delivery of nucleic acid carriers for efficient delivery from collagen
#175Functionalized Prussian blue nanoparticles, combination Prussian blue nanoparticle-based nano-immunotherapy and applications thereof
#176Use of lambda interferons in the treatment of obesity-related disorders and related diseases
#177IMMUNE MODULATORS IN COMBINATION WITH RADIATION TREATMENT
#178STABILIZATION OF AQUEOUS COMPOSITIONS OF PROTEINS WITH DISPLACEMENT BUFFERS
#179Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
#180Composition for Use in the Treatment of an Individual Suffering a Condition Necessitating New Bone Formation
#181Topical therapeutic formulations
#182Cyclopamine analogs
#183REGULATORY B CELLS AND USES THEREOF
#184METHODS RELATED TO ADMINISTERING IMMUNOSUPPRESSANTS AND THERAPEUTIC MACROMOLECULES AT A REDUCED PHARMACODYNAMICALLY EFFECTIVE DOSE
#185Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity
#186ANTIVIRAL COMPOUNDS
#187METHODS COMPRISING DOSING COMBINATIONS FOR REDUCING UNDESIRED HUMORAL IMMUNE RESPONSES
#188METHODS OF ADMINISTERING IMMUNOSUPPRESSANTS HAVING A SPECIFIED PHARMACODYNAMIC EFFECTIVE LIFE AND THERAPEUTIC MACROMOLECULES FOR THE INDUCTION OF IMMUNE TOLERANCE
#189METHOD FOR REDUCING FLU-LIKE SYMPTOMS ASSOCIATED WITH INTRAMUSCULAR ADMINISTRATION OF INTERFERON USING A FAST TITRATION ESCALATING DOSING REGIMEN
#190S1P modulating agents
#191Lactam compound, preparation method and use thereof
#192Methods of use of cyclopamine analogs
#193NANOPARTICLE FORMULATIONS FOR ENHANCED DRUG DELIVERY TO THE BLADDER
#194Fusion proteins containing luciferase and a polypeptide of interest
#195Interferon Analogs
#196MEDICAL USE OF INTERFERON-LAMBDA FOR THE TREATMENT OF FIBROSIS
#197Peroxide removal from drug delivery vehicle
#198Inhibitors of hepatitis C virus
#199PROTEIN FORMULATIONS AND METHODS OF MAKING SAME
#200Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#201Method of treatment ovarian cancer
#202Reagents for treatment of hepatitis B virus (HBV) infection and use thereof
#203Antiviral compounds
#204ANTIVIRAL AGENT AND METHOD FOR TREATING VIRAL INFECTION
#205Modulators of toll-like receptors
#206Controlled release pharmaceutical formulations of nitazoxanide
#207Gene Therapy For Mesothelioma
#208Composition for inhibiting survival or growth of tubercle bacillus by adjusting polarization of macrophage, and method using same
#209Antiviral compositions for the treatment of infections linked to coronaviruses
#210Methods of treating a disorder associated with with insufficient stimulator of interferon genes (STING) activity
#211Methods and compositions for treating hepatitis C virus
#212Capsid assembly modulator dosing regimen
#213Antiviral compounds
#214Methods and compositions for reducing cardiac damage and other conditions
#215Methods of treating cancer
#216Diagnostics and methods for treatment of non-alcoholic hepatic steatosis and hepatic steatohepatitis, and prevention of complications thereof
#217Stabilized preparation of interferon beta variant
#218Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy
#219Combination therapy for treatment of HBV infections
#220Immunostimulant
#221Immuno-Gene Combination Therapy
#222Treatment of hepatitis delta virus infection
#223Transdermal delivery of high viscosity bioactive agents
#224COMBINATION THERAPY FOR INDUCING IMMUNE RESPONSE TO DISEASE
#225Hepatitis C virus inhibitors
#226Treatment of hepatitis delta virus infection with interferon lambda
#227Immunity-inducing agent
#228Andrographolide treats progressive forms of multiple sclerosis
#229PHARMACEUTICAL COMPOSITION OF ENTECAVIR AND PROCESS OF MANUFACTURING
#230Immuno-Gene Combination Therapy
#231Methods of treating disease by metabolic control of T-cell differentiation
#232ANTIVIRAL COMPOUNDS AND METHODS OF USE THEREOF
#233Azepane derivatives and methods of treating hepatitis B infections
#234Inhibitors of hepatitis C virus
#235Methods for determining drug efficacy for the treatment of diffuse large B-cell lymphoma, multiple myeloma, and myeloid cancers
#236Cyclopamine analogs
#237SIP modulating agents
#238Increasing cancer patient survival time by administration of dithio-containing compounds
#239Complex coacervate for controlled release and related methods
#240METHODS FOR THE TREATMENT OF DISEASES AMELIORATED BY PDE4 INHIBITION USING DOSAGE TITRATION OF APREMILAST
#241Methods and compositions for treatment of demyelinating diseases
#242Methods and compositions for treatment of bone, skin, subcutaneous, mucosal and/or submucosal cancer by percutaneous and/or transmucosal administration of interferon
#243Methods of use of cyclopamine analogs
#244METHOD FOR TREATING TUMOR BY USING RECOMBINANT INTERFERON WITH CHANGED SPATIAL CONFIGURATION
#245METHODS OF TREATING SOLID OR LYMPHATIC TUMORS BY COMBINATION THERAPY
#246Inhibition of innate immune response
#247Interferon analogs
#248D-amino acid compounds for liver disease
#249ANTIVIRAL COMPOUNDS
#250ANTIVIRAL COMPOUNDS
#251Methods for increasing levels of interferon activity with an interferon lambda 3 polypeptide
#252MODIFIED 2' AND 3'-NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS
#253METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRUSES AND PESTIVIRUSES
#254INHIBITORS AND METHODS OF INHIBITING BACTERIAL AND VIRAL PATHOGENS
#255Hepatitis C virus inhibitors
#256ALBUMIN FUSION PROTEINS
#257ANTIVIRAL COMPOUNDS
#258Methods of determining interferon having direct inhibitory effects on tumors and uses thereof
#259TREATMENT OF CANCER WITH IMMUNE STIMULATORS
#260Benefits of supplementation with N-acetylcysteine and glycine to improve glutathione levels
#261Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis C virus infection
#262Disease therapy by inducing immune response to Trop-2 expressing cells
#263METHODS AND COMPOSITIONS FOR THE TREATMENT OF EPIDERMOLYSIS BULLOSA
#264Lymph node-targeting nanoparticles
#265DIAGNOSTICS AND METHODS FOR TREATMENT OF NON-ALCOHOLIC HEPATIC STEATOSIS AND HEPATIC STEATOHEPATITIS, AND PREVENTION OF COMPLICATIONS THEREOF
#266SMALL MOLECULE ENHANCER FOR DENDRITIC CELL CANCER VACCINES
#267Use of atpenin to activate innate immunity
#268Methods of monitoring estriol therapy
#269Modulators of toll-like receptors
#270Controlled release pharmaceutical formulations of nitozoxanide
#271BRUTON'S TYROSINE KINASE INHIBITOR COMBINATIONS AND USES THEREOF
#272Fusion protein comprising , translation interrupter sequence, and interferon amino acid sequences
#273AMINO ALCOHOL DERIVATIVES FOR THE TREATMENT OF DEMYELINATING PERIPHERAL NEUROPATHIES
#274Anti-histone therapy in acute kidney injury
#275Combination of local rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer
#276Anti-PD-1 checkpoint inhibitor antibodies that block binding of PD-L1 to PD-1
#277Modulation of cancer immunity with type 2 innate lymphoid cells, interleukin 33, and/or interferon induced protein 44
#278Compositions and Methods for Treating Niemann Pick C Disease
#279Azepane derivatives and methods of treating hepatitis B infections
#280Anti-viral compositions containing PIKfyve inhibitors and use thereof
#281S1P modulating agents
#282Microdevice and method for transdermal delivery and sampling of active substances
#283Device, system and methods for the oral delivery of therapeutic compounds
#284Therapy for vitiligo
#285MICRONEEDLE ARRAYS FOR ACTIVE AGENT DELIVERY
#286ANTIVIRAL COMPOUNDS
#287HEPATITIS C ANTIVIRAL COMPOSITIONS AND METHODS
#288Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen
#289Transluminal delivery of viruses for treatment of diseased tissue
#290Methods of use of cyclopamine analogs
#291Treatment of thrombocytopenia using orally administered interferon
#292SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES
#293ANTIVIRAL COMPOUNDS
#294Non-invasive method for assessing liver fibrosis progression
#295HBV RNAse H purification and enzyme inhibitors
#296Hepatitis B antiviral agents
#297Dosage regimen for pegylated interferon
#298METHODS OF MANUFACTURING VISCOUS LIQUID PHARMACEUTICAL FORMULATIONS
#299Crystalline form of a substituted quinoline compound and pharmaceutical compositions thereof
#300Cytokines and neuroantigens for treatment of immune disorders